EP2849754
LINAGLIPTIN, A XANTHINE DERIVATIVE AS DPP-4 INHIBITOR, FOR USE IN THE TREATMENT OF SIRS AND/OR SEPSIS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
13.5.2013EP published:
14.9.2022EP application number:
13722418.4
EPO information:
European Patent Register
Max expiry date:
12.5.2033
Title in English:
LINAGLIPTIN, A XANTHINE DERIVATIVE AS DPP-4 INHIBITOR, FOR USE IN THE TREATMENT OF SIRS AND/OR SEPSISLanguage of the patent:
English
Timeline
Today
13.5.2013EP application
14.9.2022EP Publication
Owner
Name:
Boehringer Ingelheim International GmbHAddress:
Binger Strasse 173, 55216 Ingelheim am Rhein, DE
Inventor
Name:
KLEIN, ThomasAddress:
55216 Ingelheim am Rhein, DE
Name:
DAIBER, AndreasAddress:
27383 Scheessel, DE
Name:
DUGI, KlausAddress:
55216 Ingelheim am Rhein, DE
Name:
MARK, MichaelAddress:
55216 Ingelheim am Rhein, DE
Name:
MUENZEL, ThomasAddress:
55131 Mainz, DE
Priority
Number:
12167893Date:
14.5.2012Country:
EP
Classification
Categories:
A61K 31/522, A61P 29/00